These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 17208085)

  • 1. Use of disease-modifying therapies in patients hospitalized with heart failure: a population-based perspective.
    Goldberg RJ; Spencer FA; Farmer C; Lessard D; Pezzella SM; Meyer TE
    Am J Med; 2007 Jan; 120(1):98.e1-8. PubMed ID: 17208085
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term trends in first hospitalization for heart failure and subsequent survival between 1986 and 2003: a population study of 5.1 million people.
    Jhund PS; Macintyre K; Simpson CR; Lewsey JD; Stewart S; Redpath A; Chalmers JW; Capewell S; McMurray JJ
    Circulation; 2009 Feb; 119(4):515-23. PubMed ID: 19153268
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Decompensated heart failure in the setting of kidney dysfunction: a community-wide perspective.
    Ismailov RM; Goldberg RJ; Lessard D; Spencer FA
    Nephron Clin Pract; 2007; 107(4):c147-55. PubMed ID: 17957126
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Organized Program to Initiate Lifesaving Treatment in Hospitalized Patients with Heart Failure (OPTIMIZE-HF): rationale and design.
    Fonarow GC; Abraham WT; Albert NM; Gattis WA; Gheorghiade M; Greenberg B; O'Connor CM; Yancy CW; Young J
    Am Heart J; 2004 Jul; 148(1):43-51. PubMed ID: 15215791
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A survey of outpatient management of elderly heart failure patients in Poland-treatment patterns.
    Rywik TM; Rywik SL; Korewicki J; Broda G; Sarnecka A; Drewla J
    Int J Cardiol; 2004 Jun; 95(2-3):177-84. PubMed ID: 15193817
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Factors influencing medical treatment of heart failure patients in Spanish internal medicine departments: a national survey.
    Román-Sánchez P; Conthe P; García-Alegría J; Forteza-Rey J; Montero M; Montoto C
    QJM; 2005 Feb; 98(2):127-38. PubMed ID: 15655095
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Value of medical therapy in patients >80 years of age with heart failure and preserved ejection fraction.
    Tehrani F; Phan A; Chien CV; Morrissey RP; Rafique AM; Schwarz ER
    Am J Cardiol; 2009 Mar; 103(6):829-33. PubMed ID: 19268740
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term survival after heart failure: a contemporary population-based perspective.
    Goldberg RJ; Ciampa J; Lessard D; Meyer TE; Spencer FA
    Arch Intern Med; 2007 Mar; 167(5):490-6. PubMed ID: 17353497
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Venous thromboembolism prophylaxis in hospitalized heart failure patients.
    Jois-Bilowich P; Michota F; Bartholomew JR; Glauser J; Diercks D; Weber J; Fonarow GC; Emerman CL; Peacock WF;
    J Card Fail; 2008 Mar; 14(2):127-32. PubMed ID: 18325459
    [TBL] [Abstract][Full Text] [Related]  

  • 10. How well are chronic heart failure patients being managed?
    Fonarow GC
    Rev Cardiovasc Med; 2006; 7 Suppl 1():S3-11. PubMed ID: 16955055
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Optimal medical therapy at discharge in patients with acute coronary syndromes: temporal changes, characteristics, and 1-year outcome.
    Yan AT; Yan RT; Tan M; Huynh T; Soghrati K; Brunner LJ; DeYoung P; Fitchett DH; Langer A; Goodman SG;
    Am Heart J; 2007 Dec; 154(6):1108-15. PubMed ID: 18035083
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy of medical therapy for the reduction of heart failure events in patients with implanted cardioverter defibrillators.
    Pietrasik G; Goldenberg I; McNitt S; Polonsky B; Moss AJ; Zareba W
    J Cardiovasc Electrophysiol; 2009 Apr; 20(4):395-400. PubMed ID: 19017351
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Outpatient medical and nurse management program in patients with chronic heart failure in a large territorial area in Piedmont. Four years of follow-up].
    Conte MR; Mainardi L; Iazzolino E; Casetta M; Asteggiano R; Lai F; Lusardi R; Sasso L
    Ital Heart J Suppl; 2005 Dec; 6(12):812-20. PubMed ID: 16444925
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Digoxin and clinical outcomes in systolic heart failure patients on contemporary background heart failure therapy.
    Dhaliwal AS; Bredikis A; Habib G; Carabello BA; Ramasubbu K; Bozkurt B
    Am J Cardiol; 2008 Nov; 102(10):1356-60. PubMed ID: 18993155
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Predictors of mortality after discharge in patients hospitalized with heart failure: an analysis from the Organized Program to Initiate Lifesaving Treatment in Hospitalized Patients with Heart Failure (OPTIMIZE-HF).
    O'Connor CM; Abraham WT; Albert NM; Clare R; Gattis Stough W; Gheorghiade M; Greenberg BH; Yancy CW; Young JB; Fonarow GC
    Am Heart J; 2008 Oct; 156(4):662-73. PubMed ID: 18926148
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Use of nonpharmacologic treatment approaches in patients with heart failure.
    Goldberg RJ; Farmer C; Spencer FA; Pezzella S; Meyer TE
    Int J Cardiol; 2006 Jun; 110(3):348-53. PubMed ID: 16503057
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adherence to guidelines for patients hospitalized with heart failure: a nationwide survey.
    Jotkowitz AB; Porath A; Shotan A; Mittelman M; Grossman E; Zimlichman R; Lewis BS; Caspi A; Gottlieb S; Garty M;
    Isr Med Assoc J; 2006 Dec; 8(12):875-9. PubMed ID: 17214110
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Retrospective claims database analysis to determine relationship between renin-angiotensin system agents, rehospitalization, and health care costs in patients with heart failure or myocardial infarction.
    Sun SX; Ye X; Lee KY; Dupclay L; Plauschinat C
    Clin Ther; 2008; 30 Pt 2():2217-27. PubMed ID: 19281916
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Decade-long trends (1986 to 1997) in the medical treatment of patients with acute myocardial infarction: A community-wide perspective.
    Spencer F; Scleparis G; Goldberg RJ; Yarzebski J; Lessard D; Gore JM
    Am Heart J; 2001 Oct; 142(4):594-603. PubMed ID: 11579348
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Incremental effects of concurrent pharmacotherapeutic regimens for heart failure on hospitalizations and costs.
    Skrepnek GH; Abarca J; Malone DC; Armstrong EP; Shirazi FM; Woosley RL
    Ann Pharmacother; 2005 Nov; 39(11):1785-91. PubMed ID: 16219900
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.